This report provides comprehensive information on the current therapeutic developmental pipeline of Genzyme Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
http://www.researchmoz.us/genzyme-corporation-product-pipeline-review-2015-report.html
1. Genzyme Corporation - Product Pipeline Review - 2015
Global Markets Directs, Genzyme Corporation Product Pipeline Review 2015, provides an overview of the Genzyme Corporations pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Genzyme Corporations, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Genzyme Corporation including business description, key information and facts, and its locations and subsidiaries The
report reviews current pipeline of Genzyme Corporations human therapeutic division and enlists all their major and minor projects The report features product
description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature
on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news
and deals relating to the Genzyme Corporations pipeline products
Reasons to buy
Evaluate Genzyme Corporations strategic position with total access to detailed information on its product pipeline Assess the growth potential of Genzyme
Corporation in its therapy areas of focus Identify new drug targets and therapeutic classes in the Genzyme Corporations R&D portfolio and develop key strategic
initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic
initiatives by understanding the focus areas of Genzyme Corporation and exploit collaboration and partnership opportunities Identify emerging players with
potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying
the most promising pipeline of Genzyme Corporation Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of Genzyme Corporation and identify
potential opportunities in those areas Avoid Intellectual Property Rights related issues
table Of Contents
table Of Contents 2
list Of Tables 5
list Of Figures 5
genzyme Corporation Snapshot 6
genzyme Corporation Overview 6
key Information 6
key Facts 6
genzyme Corporation - Research And Development Overview 7
key Therapeutic Areas 7
genzyme Corporation - Pipeline Review 10
pipeline Products By Stage Of Development 10
pipeline Products - Monotherapy 11
pipeline Products - Partnered Products 12
partnered Products/combination Treatment Modalities 13
genzyme Corporation - Pipeline Products Glance 14
genzyme Corporation - Late Stage Pipeline Products 14
pre-registration Products/combination Treatment Modalities 14
phase Iii Products/combination Treatment Modalities 15
genzyme Corporation - Clinical Stage Pipeline Products 16
phase Ii Products/combination Treatment Modalities 16
phase I Products/combination Treatment Modalities 17
genzyme Corporation - Early Stage Pipeline Products 18
preclinical Products/combination Treatment Modalities 18
discovery Products/combination Treatment Modalities 19
genzyme Corporation - Drug Profiles 20
eliglustat Tartrate 20
product Description 20
mechanism Of Action 20
r&d Progress 20
patisiran 22
product Description 22
Genzyme Corporation - Product Pipeline Review - 2015
2. mechanism Of Action 22
r&d Progress 22
revusiran 23
product Description 23
mechanism Of Action 23
r&d Progress 23
sargramostim 25
product Description 25
mechanism Of Action 25
r&d Progress 25
gz-402666 27
product Description 27
mechanism Of Action 27
r&d Progress 27
fresolimumab 28
product Description 28
mechanism Of Action 28
r&d Progress 28
genz-682452 30
product Description 30
mechanism Of Action 30
r&d Progress 30
gz-402671 31
product Description 31
mechanism Of Action 31
r&d Progress 31
olipodase 32
product Description 32
mechanism Of Action 32
r&d Progress 32
gz-402663 33
product Description 33
mechanism Of Action 33
r&d Progress 33
gz-402668 34
product Description 34
mechanism Of Action 34
r&d Progress 34
1d-11 35
product Description 35
mechanism Of Action 35
r&d Progress 35
antisense Oligonucleotide For Spinal Muscular Atrophy And Myotonic Dystrophy 36
product Description 36
mechanism Of Action 36
r&d Progress 36
gene Therapy To Activate Smn1 For Spinal Muscular Atrophy 37
product Description 37
mechanism Of Action 37
r&d Progress 37
genz-644442 38
product Description 38
mechanism Of Action 38
r&d Progress 38
genz-668764 39
product Description 39
mechanism Of Action 39
r&d Progress 39
small Molecules For Malaria 40
product Description 40
mechanism Of Action 40
r&d Progress 40
small Molecules To Inhibit Pmp22 For Charcot-marie-tooth Type 1 A 41
product Description 41
mechanism Of Action 41
r&d Progress 41
genzyme Corporation - Pipeline Analysis 42
genzyme Corporation - Pipeline Products By Target 42
Genzyme Corporation - Product Pipeline Review - 2015
3. genzyme Corporation - Pipeline Products By Route Of Administration 44
genzyme Corporation - Pipeline Products By Molecule Type 45
genzyme Corporation - Pipeline Products By Mechanism Of Action 46
genzyme Corporation - Recent Pipeline Updates 47
genzyme Corporation - Dormant Projects 58
genzyme Corporation - Discontinued Pipeline Products 60
discontinued Pipeline Product Profiles 60
ataluren 60
genz-644470 60
gz-402674 60
gz-404477 60
metelimumab 61
tasidotin Hydrochloride 61
teriflunomide 61
tolevamer Potassium Sodium 61
genzyme Corporation - Locations And Subsidiaries 62
head Office 62
other Locations & Subsidiaries 62
genzyme Corporation - Key Manufacturing Facilities 72
appendix 73
methodology 73
coverage 73
secondary Research 73
primary Research 73
expert Panel Validation 73
contact Us 73
disclaimer 74
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Genzyme Corporation - Product Pipeline Review - 2015
